Digital version of the SAGE test
The SAGE test was developed by Dr. Scharre at Ohio State and licensed to BrainTest. You can download a mobile app version of the SAGE test at https://Braintest.com
To download the SAGE test, please first agree to our terms of use.
Download the testLearn more about how to take the SAGE test and what to do after you complete the test.
More about the SAGE testGet information about how to administer and interpret the SAGE test as a physician.
For physiciansI understand that The Ohio State University Wexner Medical Center provides this instrument and accompanying interpretive guidelines (collectively the "Instrument") as an informational service. Use of the Instrument is governed by the terms and conditions. Please read the statements carefully before accessing or using the Instrument. By accessing or using the Instrument, you agree to be bound by all the terms and conditions herein.
The Instrument cannot substitute for medical advice, diagnosis or treatment by a trained medical professional. Diagnosis and treatment of human illness should be based collectively on medical history, including family medical history, and a physical examination along with a doctor's professional judgment and review of all test results. The material contained in the Instrument does not contain standards that are meant to be applied rigidly and followed in virtually all cases. Physicians' judgment must remain central to the selection of diagnostic tests and therapy options of a specific patient's medical condition.
Permission is granted to use this Instrument for individual clinical, noncommercial educational, and noncommercial (NOT funded by a commercial entity) research use only, provided that The Ohio State University and authors of the Instrument are acknowledged in any publications reporting its use, and the name of The Ohio State University or any of its officers, employees, students, or board members is not used in any advertising or publicity pertaining to the use or distribution of the Instrument without specific, written prior authorization. Permission to modify or otherwise create derivative works of the Instrument or to redistribute the Instrument and its derivatives is not granted. Those desiring to utilize the Instrument for commercial purposes (including clinical trials, incorporation into commercial products, and performance of contract research), for translating or creating derivatives, or for promotional purposes (including press releases), should contact the Technology Commercialization Office, 614-292-1315, corporateengagement@osu.edu.
The Instrument is provided AS IS, WITHOUT REPRESENTATION AS TO ITS FITNESS FOR ANY PURPOSE, AND WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. No guarantees are made with respect to accuracy, completeness, errors, or omissions of content. The Ohio State University has no obligation to provide support, updates, enhancements, or other modifications. In no event will the Ohio State University be liable for any decision made or action taken in reliance upon the information provided through the Instrument. THE OHIO STATE UNIVERSITY SHALL NOT BE LIABLE FOR ANY COMPENSATORY OR NON-COMPENSATORY DAMAGES, INCLUDING BUT NOT LIMITED TO SPECIAL, INDIRECT, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, WITH RESPECT TO ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH THE USE OF THE INSTRUMENT, EVEN IF IT HAS BEEN OR IS HEREAFTER ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
By clicking the button below, you agree to the terms and conditions stated above.
Hear from Douglas Scharre, MD, who developed the test with his team at The Ohio State University Wexner Medical Center about the SAGE test.
In the decades since, the scope of this work at Ohio State has blossomed tremendously, facilitating a multitude of new treatment options for patients and their family members grappling with devastating memory loss issues.
You may want to take SAGE if you are concerned that you might have cognitive issues. Or you may wish to have your family or friends take the test if they are having memory or thinking problems. The difficulties listed can be early signs of cognitive and brain dysfunction. While dementia or Alzheimer's disease can lead to these symptoms, there are many other treatable disorders that also may cause these signs.
It is normal to experience some memory loss and to take longer to recall events as you age. But if the changes you are experiencing are worrying you or others around you, SAGE can be a helpful tool to assess if further evaluation is necessary.
You don't need special equipment to take SAGE — just a pen and paper. There are four forms of the SAGE test. You only need to take one. It doesn't matter which one you take; they are all interchangeable.
Don't look at the clock or calendar while taking the test, and if you have questions about an item, just do the best you can. The average time to complete this four-page test is 10 to 15 minutes, but there is no time limit.
Depending on your score, your doctor may schedule follow-up tests or simply keep it on file so he can see if there are any changes down the road.
Unfortunately, many people do not seek help for these kinds of symptoms until they have experienced them for several years. There are many treatable causes of cognitive and thinking loss, and in some cases, medications or other treatments can be very effective-especially if provided when symptoms first begin.
Remember that SAGE does not diagnose any specific condition. The results of SAGE will not tell you if you have Alzheimer's disease, mini-strokes or any number of other disorders. But the results can help your doctor know if further evaluation is necessary.
After you complete the test, take it to your primary care physician. Your doctor will score it and interpret the results. Your doctor may schedule some tests to further evaluate your symptoms or refer you for further evaluation.
If your score does not indicate any need for further evaluation, your doctor can keep the test on file as a baseline for the future. That means, you can take the test again in the future, and the doctor can see if there are any changes over time.
There is no answer sheet provided here for you to score yourself because there are multiple correct answers to many of the questions on the test. SAGE should be scored by your physician.
If you don't have a primary care physician, view our list of primary care providers accepting new patients.
The SAGE test was developed by Dr. Scharre at Ohio State and licensed to BrainTest. You can download a mobile app version of the SAGE test at https://Braintest.com
The test is self-administered and can be taken at a person's home, in a physician's office or virtually anywhere. It requires no special equipment – only pen and paper.
There are four forms of the SAGE test. Only one test form should be given. It does not matter which form is taken, as they are all interchangeable. Multiple forms are provided to reduce practice effect for patients who may take the test more than once and are useful when rapidly screening larger numbers of individuals at the same time.
The steps to administer the test are as follows:
Inform the examinee that there are four pages to complete.
Examinees who download SAGE from the Internet and take it at home are instructed to bring their completed test to their primary care physician. Scoring instructions and explanations for physicians are below:
Scoring Instructions: English US/UK, English NZ, Spanish, Italian, Dutch, Croatian, French, German, Polish, Arabic
Scoring Explanation: English US/UK, English NZ, Spanish, Italian, Dutch, Croatian, French, German, Polish, Arabic
The Self-Administered Gerocognitive Exam (SAGE) is a brief self-administered cognitive screening instrument used to identify mild cognitive impairment (MCI) from any cause and early dementia. The questions are more difficult than other similar questionnaires, such as the Mini-Mental State Examination (MMSE), to pick up those with very mild impairments. There is no fee to use SAGE for individual clinical use and noncommercial educational use.
Researchers at Ohio State evaluated study participants using SAGE and then evaluated the same subjects with other established assessment tools. The test has a sensitivity of 79 percent and a false positive rate of 5 percent in detecting cognitive impairment from normal subjects. Results were published in the January-March 2010 issue of Alzheimer's Disease & Associated Disorders.
In another study, researchers at Ohio State performed an item analysis of the test questions. Results were published in the Winter 2014 issue of The Journal of Neuropsychiatry & Clinical Neurosciences.
These tables and figures provide validity and normative data on SAGE.
Examinees who download SAGE from the Internet and take it at home are instructed to bring their completed test to their primary care physician. Scoring instructions and explanations for physicians are below:
Scoring Instructions: English US/UK, English NZ, Spanish, Italian, Dutch, Croatian, French, German, Polish, Thai, Arabic, Japanese, Slovenian
Scoring Explanation: English US/UK, English NZ, Spanish, Italian, Dutch, Croatian, French, German, Polish, Thai, Arabic, Japanese, Slovenian
The Self-Administered Gerocognitive Exam (SAGE) is a brief self-administered cognitive screening instrument used to identify mild cognitive impairment (MCI) from any cause and early dementia. The questions are more difficult than other similar questionnaires, such as the Mini-Mental State Examination (MMSE), to pick up those with very mild impairments. There is no fee to use SAGE for individual clinical use and noncommercial educational use.
Researchers at Ohio State evaluated study participants using SAGE and then evaluated the same subjects with other established assessment tools. The test has a sensitivity of 79 percent and a false positive rate of 5 percent in detecting cognitive impairment from normal subjects. Results were published in the January-March 2010 issue of Alzheimer's Disease & Associated Disorders.
In another study, researchers at Ohio State performed an item analysis of the test questions. Results were published in the Winter 2014 issue of The Journal of Neuropsychiatry & Clinical Neurosciences.
Douglas Scharre, MD
Director, Division of Cognitive Neurology
The Ohio State University Wexner Medical Center
614-293-4969